Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 07-2000 | 06-2000 | 04-2000 | 03-2000 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -250 | -250 | -910 | -910 |
| Depreciation Amortization | 7 | 7 | 50 | 50 |
| Other Working Capital | 40 | 40 | -120 | -120 |
| Other Operating Activity | 3 | 3 | 70 | 70 |
| Operating Cash Flow | $-200 | $-200 | $-910 | $-910 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -90 | -90 | -10 | -10 |
| Other Investing Activity | -30 | -30 | -40 | -40 |
| Investing Cash Flow | $-120 | $-120 | $-50 | $-50 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 430 | 430 | 6,230 | 6,230 |
| Financing Cash Flow | $430 | $430 | $6,230 | $6,230 |
| Beginning Cash Position | 5,460 | 5,460 | 190 | 190 |
| End Cash Position | 5,570 | 5,570 | 5,460 | 5,460 |
| Net Cash Flow | $100 | $100 | $5,270 | $5,270 |
| Free Cash Flow | ||||
| Operating Cash Flow | -200 | -200 | -910 | -910 |
| Free Cash Flow | -200 | -200 | -910 | -910 |